Cargando…
Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [(18)F]-fluoro-azomycinarabino-furanoside ([(18)F]FAZA)
BACKGROUND: [(18)F]FAZA is a PET biomarker with great potential for imaging tumor hypoxia. Aim of our study was to compare [(18)F]FAZA uptake in mice with subcutaneous exogenous CT26 colon carcinomas and endogenous polyoma middle-T (PyV-mT) mammary carcinomas and to analyze the influence of differen...
Autores principales: | Maier, Florian C, Kneilling, Manfred, Reischl, Gerald, Cay, Funda, Bukala, Daniel, Schmid, Andreas, Judenhofer, Martin S, Röcken, Martin, Machulla, Hans-Jürgen, Pichler, Bernd J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283532/ https://www.ncbi.nlm.nih.gov/pubmed/22118419 http://dx.doi.org/10.1186/1748-717X-6-165 |
Ejemplares similares
-
A Comparative pO(2) Probe and [(18)F]-Fluoro-Azomycinarabino-Furanoside ([(18)F]FAZA) PET Study Reveals Anesthesia-Induced Impairment of Oxygenation and Perfusion in Tumor and Muscle
por: Mahling, Moritz, et al.
Publicado: (2015) -
2-Nitroimidazole-Furanoside Derivatives for Hypoxia Imaging—Investigation of Nucleoside Transporter Interaction, (18)F-Labeling and Preclinical PET Imaging
por: Maier, Florian C., et al.
Publicado: (2019) -
First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer
por: Thureau, Sébastien, et al.
Publicado: (2021) -
Technical feasibility of [(18)F]FET and [(18)F]FAZA PET guided radiotherapy in a F98 glioblastoma rat model
por: Verhoeven, Jeroen, et al.
Publicado: (2019) -
Kinetic Evaluation of the Hypoxia Radiotracers [(18)F]FMISO and [(18)F]FAZA in Dogs with Spontaneous Tumors Using Dynamic PET/CT Imaging
por: Choen, Sangkyung, et al.
Publicado: (2022)